Cargando…

Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test – which method to choose for the diagnosis?

BACKGROUND: Antiretroviral therapy dramatically reduced HIV-related morbidity and mortality, prolonging the lifespan of HIV-infected patients. Greater duration of infection and exposure to antiretroviral therapy makes these patients susceptible to traditional cardio-metabolic risk factors and pathol...

Descripción completa

Detalles Bibliográficos
Autores principales: Coelho, Ana Rita, Moreira, Flávia Andreia, Santos, Ana Cristina, Silva-Pinto, André, Sarmento, António, Carvalho, Davide, Freitas, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035413/
https://www.ncbi.nlm.nih.gov/pubmed/29980190
http://dx.doi.org/10.1186/s12879-018-3221-7
_version_ 1783338047439372288
author Coelho, Ana Rita
Moreira, Flávia Andreia
Santos, Ana Cristina
Silva-Pinto, André
Sarmento, António
Carvalho, Davide
Freitas, Paula
author_facet Coelho, Ana Rita
Moreira, Flávia Andreia
Santos, Ana Cristina
Silva-Pinto, André
Sarmento, António
Carvalho, Davide
Freitas, Paula
author_sort Coelho, Ana Rita
collection PubMed
description BACKGROUND: Antiretroviral therapy dramatically reduced HIV-related morbidity and mortality, prolonging the lifespan of HIV-infected patients. Greater duration of infection and exposure to antiretroviral therapy makes these patients susceptible to traditional cardio-metabolic risk factors and pathologies. The optimal diagnostic protocol for Diabetes Mellitus in these patients is still controversial. Haemoglobin A1c (HbA1c) has been shown to underestimate glycaemia levels and the oral glucose tolerance test (OGTT) has been shown to reveal cases of glucose metabolism disturbances in patients with normal fasting glucose. Thus, this study aimed to determine the prevalence of prediabetes and diabetes in a population of HIV-infected patients undergoing combined antiretroviral therapy, using three different diagnostic methods (fasting glucose, OGTT and HbA1c), to determine the agreement between the different methods and the characteristics associated with each one. METHODS: This study analyzed 220 HIV-infected patients on antiretroviral therapy. Patient characteristics were collected using a standardized protocol. Disturbances of glucose homeostasis were defined by the ADA 2017 criteria. Patients were characterized according to the presence or absence of clinical lipodystrophy, and distributed into four different categories, according to the presence, or absence of either clinical lipoatrophy, or abdominal prominence. Insulin resistance was assessed by HOMA-IR and QUICKI indexes. Agreement between the diagnostic methods was assessed by Cohen’s kappa coefficient. RESULTS: There were no patients diagnosed with diabetes with HbA1c. 5.9% prevalence was obtained when OGTT was used, and 3.2% prevalence when fasting glucose was used. Prediabetes had a prevalence of 14.1% when using HbA1c, 24.1% when using OGTT, and 20% when using fasting glucose. In all three methods, glucose homeostasis disturbances were associated with older age and higher resistance to insulin. Regarding other characteristics, associations varied between the three methods. The agreement between them was fair, or slight. CONCLUSIONS: We observed that HbA1c was the method that diagnosed the least amount of cases and that OGTT was the one that diagnosed the most cases. Accordingly, our results indicate that HbA1c underestimated glycaemia levels in this population and that the use of OGTT might allow an earlier diagnosis of glucose homeostasis disturbances, potentially making it possible to avoid severe complications of DM.
format Online
Article
Text
id pubmed-6035413
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60354132018-07-09 Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test – which method to choose for the diagnosis? Coelho, Ana Rita Moreira, Flávia Andreia Santos, Ana Cristina Silva-Pinto, André Sarmento, António Carvalho, Davide Freitas, Paula BMC Infect Dis Research Article BACKGROUND: Antiretroviral therapy dramatically reduced HIV-related morbidity and mortality, prolonging the lifespan of HIV-infected patients. Greater duration of infection and exposure to antiretroviral therapy makes these patients susceptible to traditional cardio-metabolic risk factors and pathologies. The optimal diagnostic protocol for Diabetes Mellitus in these patients is still controversial. Haemoglobin A1c (HbA1c) has been shown to underestimate glycaemia levels and the oral glucose tolerance test (OGTT) has been shown to reveal cases of glucose metabolism disturbances in patients with normal fasting glucose. Thus, this study aimed to determine the prevalence of prediabetes and diabetes in a population of HIV-infected patients undergoing combined antiretroviral therapy, using three different diagnostic methods (fasting glucose, OGTT and HbA1c), to determine the agreement between the different methods and the characteristics associated with each one. METHODS: This study analyzed 220 HIV-infected patients on antiretroviral therapy. Patient characteristics were collected using a standardized protocol. Disturbances of glucose homeostasis were defined by the ADA 2017 criteria. Patients were characterized according to the presence or absence of clinical lipodystrophy, and distributed into four different categories, according to the presence, or absence of either clinical lipoatrophy, or abdominal prominence. Insulin resistance was assessed by HOMA-IR and QUICKI indexes. Agreement between the diagnostic methods was assessed by Cohen’s kappa coefficient. RESULTS: There were no patients diagnosed with diabetes with HbA1c. 5.9% prevalence was obtained when OGTT was used, and 3.2% prevalence when fasting glucose was used. Prediabetes had a prevalence of 14.1% when using HbA1c, 24.1% when using OGTT, and 20% when using fasting glucose. In all three methods, glucose homeostasis disturbances were associated with older age and higher resistance to insulin. Regarding other characteristics, associations varied between the three methods. The agreement between them was fair, or slight. CONCLUSIONS: We observed that HbA1c was the method that diagnosed the least amount of cases and that OGTT was the one that diagnosed the most cases. Accordingly, our results indicate that HbA1c underestimated glycaemia levels in this population and that the use of OGTT might allow an earlier diagnosis of glucose homeostasis disturbances, potentially making it possible to avoid severe complications of DM. BioMed Central 2018-07-06 /pmc/articles/PMC6035413/ /pubmed/29980190 http://dx.doi.org/10.1186/s12879-018-3221-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Coelho, Ana Rita
Moreira, Flávia Andreia
Santos, Ana Cristina
Silva-Pinto, André
Sarmento, António
Carvalho, Davide
Freitas, Paula
Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test – which method to choose for the diagnosis?
title Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test – which method to choose for the diagnosis?
title_full Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test – which method to choose for the diagnosis?
title_fullStr Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test – which method to choose for the diagnosis?
title_full_unstemmed Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test – which method to choose for the diagnosis?
title_short Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test – which method to choose for the diagnosis?
title_sort diabetes mellitus in hiv-infected patients: fasting glucose, a1c, or oral glucose tolerance test – which method to choose for the diagnosis?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035413/
https://www.ncbi.nlm.nih.gov/pubmed/29980190
http://dx.doi.org/10.1186/s12879-018-3221-7
work_keys_str_mv AT coelhoanarita diabetesmellitusinhivinfectedpatientsfastingglucosea1cororalglucosetolerancetestwhichmethodtochooseforthediagnosis
AT moreiraflaviaandreia diabetesmellitusinhivinfectedpatientsfastingglucosea1cororalglucosetolerancetestwhichmethodtochooseforthediagnosis
AT santosanacristina diabetesmellitusinhivinfectedpatientsfastingglucosea1cororalglucosetolerancetestwhichmethodtochooseforthediagnosis
AT silvapintoandre diabetesmellitusinhivinfectedpatientsfastingglucosea1cororalglucosetolerancetestwhichmethodtochooseforthediagnosis
AT sarmentoantonio diabetesmellitusinhivinfectedpatientsfastingglucosea1cororalglucosetolerancetestwhichmethodtochooseforthediagnosis
AT carvalhodavide diabetesmellitusinhivinfectedpatientsfastingglucosea1cororalglucosetolerancetestwhichmethodtochooseforthediagnosis
AT freitaspaula diabetesmellitusinhivinfectedpatientsfastingglucosea1cororalglucosetolerancetestwhichmethodtochooseforthediagnosis